# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000886163-20-000110
Filing Date
2020-10-20
Accepted
2020-10-20 10:52:40
Documents
146
Period of Report
2020-10-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | lgnd-20201020.htm iXBRL | 8-K | 41331
2 | EX-99.1 | a201020investorandanalys.htm | EX-99.1 | 167255
8 | GRAPHIC | a201020investorandanalys001.jpg | GRAPHIC | 87977
9 | GRAPHIC | a201020investorandanalys002.jpg | GRAPHIC | 255273
10 | GRAPHIC | a201020investorandanalys003.jpg | GRAPHIC | 97928
11 | GRAPHIC | a201020investorandanalys004.jpg | GRAPHIC | 57058
12 | GRAPHIC | a201020investorandanalys005.jpg | GRAPHIC | 104401
13 | GRAPHIC | a201020investorandanalys006.jpg | GRAPHIC | 81679
14 | GRAPHIC | a201020investorandanalys007.jpg | GRAPHIC | 92459
15 | GRAPHIC | a201020investorandanalys008.jpg | GRAPHIC | 90922
16 | GRAPHIC | a201020investorandanalys009.jpg | GRAPHIC | 80443
17 | GRAPHIC | a201020investorandanalys010.jpg | GRAPHIC | 38777
18 | GRAPHIC | a201020investorandanalys011.jpg | GRAPHIC | 62875
19 | GRAPHIC | a201020investorandanalys012.jpg | GRAPHIC | 54835
20 | GRAPHIC | a201020investorandanalys013.jpg | GRAPHIC | 70625
21 | GRAPHIC | a201020investorandanalys014.jpg | GRAPHIC | 52039
22 | GRAPHIC | a201020investorandanalys015.jpg | GRAPHIC | 103747
23 | GRAPHIC | a201020investorandanalys016.jpg | GRAPHIC | 108056
24 | GRAPHIC | a201020investorandanalys017.jpg | GRAPHIC | 77556
25 | GRAPHIC | a201020investorandanalys018.jpg | GRAPHIC | 51296
26 | GRAPHIC | a201020investorandanalys019.jpg | GRAPHIC | 114869
27 | GRAPHIC | a201020investorandanalys020.jpg | GRAPHIC | 90490
28 | GRAPHIC | a201020investorandanalys021.jpg | GRAPHIC | 130235
29 | GRAPHIC | a201020investorandanalys022.jpg | GRAPHIC | 67349
30 | GRAPHIC | a201020investorandanalys023.jpg | GRAPHIC | 45576
31 | GRAPHIC | a201020investorandanalys024.jpg | GRAPHIC | 98786
32 | GRAPHIC | a201020investorandanalys025.jpg | GRAPHIC | 157652
33 | GRAPHIC | a201020investorandanalys026.jpg | GRAPHIC | 42711
34 | GRAPHIC | a201020investorandanalys027.jpg | GRAPHIC | 121430
35 | GRAPHIC | a201020investorandanalys028.jpg | GRAPHIC | 118512
36 | GRAPHIC | a201020investorandanalys029.jpg | GRAPHIC | 109886
37 | GRAPHIC | a201020investorandanalys030.jpg | GRAPHIC | 88619
38 | GRAPHIC | a201020investorandanalys031.jpg | GRAPHIC | 127142
39 | GRAPHIC | a201020investorandanalys032.jpg | GRAPHIC | 135837
40 | GRAPHIC | a201020investorandanalys033.jpg | GRAPHIC | 70342
41 | GRAPHIC | a201020investorandanalys034.jpg | GRAPHIC | 46282
42 | GRAPHIC | a201020investorandanalys035.jpg | GRAPHIC | 92857
43 | GRAPHIC | a201020investorandanalys036.jpg | GRAPHIC | 107690
44 | GRAPHIC | a201020investorandanalys037.jpg | GRAPHIC | 136049
45 | GRAPHIC | a201020investorandanalys038.jpg | GRAPHIC | 100058
46 | GRAPHIC | a201020investorandanalys039.jpg | GRAPHIC | 74454
47 | GRAPHIC | a201020investorandanalys040.jpg | GRAPHIC | 62275
48 | GRAPHIC | a201020investorandanalys041.jpg | GRAPHIC | 107352
49 | GRAPHIC | a201020investorandanalys042.jpg | GRAPHIC | 106159
50 | GRAPHIC | a201020investorandanalys043.jpg | GRAPHIC | 88883
51 | GRAPHIC | a201020investorandanalys044.jpg | GRAPHIC | 107279
52 | GRAPHIC | a201020investorandanalys045.jpg | GRAPHIC | 85013
53 | GRAPHIC | a201020investorandanalys046.jpg | GRAPHIC | 63858
54 | GRAPHIC | a201020investorandanalys047.jpg | GRAPHIC | 128513
55 | GRAPHIC | a201020investorandanalys048.jpg | GRAPHIC | 62976
56 | GRAPHIC | a201020investorandanalys049.jpg | GRAPHIC | 97408
57 | GRAPHIC | a201020investorandanalys050.jpg | GRAPHIC | 87875
58 | GRAPHIC | a201020investorandanalys051.jpg | GRAPHIC | 92343
59 | GRAPHIC | a201020investorandanalys052.jpg | GRAPHIC | 84012
60 | GRAPHIC | a201020investorandanalys053.jpg | GRAPHIC | 59110
61 | GRAPHIC | a201020investorandanalys054.jpg | GRAPHIC | 117679
62 | GRAPHIC | a201020investorandanalys055.jpg | GRAPHIC | 75440
63 | GRAPHIC | a201020investorandanalys056.jpg | GRAPHIC | 39360
64 | GRAPHIC | a201020investorandanalys057.jpg | GRAPHIC | 49639
65 | GRAPHIC | a201020investorandanalys058.jpg | GRAPHIC | 100503
66 | GRAPHIC | a201020investorandanalys059.jpg | GRAPHIC | 59691
67 | GRAPHIC | a201020investorandanalys060.jpg | GRAPHIC | 77937
68 | GRAPHIC | a201020investorandanalys061.jpg | GRAPHIC | 58048
69 | GRAPHIC | a201020investorandanalys062.jpg | GRAPHIC | 68039
70 | GRAPHIC | a201020investorandanalys063.jpg | GRAPHIC | 54193
71 | GRAPHIC | a201020investorandanalys064.jpg | GRAPHIC | 82926
72 | GRAPHIC | a201020investorandanalys065.jpg | GRAPHIC | 89239
73 | GRAPHIC | a201020investorandanalys066.jpg | GRAPHIC | 73094
74 | GRAPHIC | a201020investorandanalys067.jpg | GRAPHIC | 81311
75 | GRAPHIC | a201020investorandanalys068.jpg | GRAPHIC | 81497
76 | GRAPHIC | a201020investorandanalys069.jpg | GRAPHIC | 119863
77 | GRAPHIC | a201020investorandanalys070.jpg | GRAPHIC | 101616
78 | GRAPHIC | a201020investorandanalys071.jpg | GRAPHIC | 74817
79 | GRAPHIC | a201020investorandanalys072.jpg | GRAPHIC | 69880
80 | GRAPHIC | a201020investorandanalys073.jpg | GRAPHIC | 94334
81 | GRAPHIC | a201020investorandanalys074.jpg | GRAPHIC | 108767
82 | GRAPHIC | a201020investorandanalys075.jpg | GRAPHIC | 82791
83 | GRAPHIC | a201020investorandanalys076.jpg | GRAPHIC | 124194
84 | GRAPHIC | a201020investorandanalys077.jpg | GRAPHIC | 88003
85 | GRAPHIC | a201020investorandanalys078.jpg | GRAPHIC | 90719
86 | GRAPHIC | a201020investorandanalys079.jpg | GRAPHIC | 115297
87 | GRAPHIC | a201020investorandanalys080.jpg | GRAPHIC | 100981
88 | GRAPHIC | a201020investorandanalys081.jpg | GRAPHIC | 80451
89 | GRAPHIC | a201020investorandanalys082.jpg | GRAPHIC | 66278
90 | GRAPHIC | a201020investorandanalys083.jpg | GRAPHIC | 113929
91 | GRAPHIC | a201020investorandanalys084.jpg | GRAPHIC | 37926
92 | GRAPHIC | a201020investorandanalys085.jpg | GRAPHIC | 60593
93 | GRAPHIC | a201020investorandanalys086.jpg | GRAPHIC | 122003
94 | GRAPHIC | a201020investorandanalys087.jpg | GRAPHIC | 102478
95 | GRAPHIC | a201020investorandanalys088.jpg | GRAPHIC | 109829
96 | GRAPHIC | a201020investorandanalys089.jpg | GRAPHIC | 124297
97 | GRAPHIC | a201020investorandanalys090.jpg | GRAPHIC | 102967
98 | GRAPHIC | a201020investorandanalys091.jpg | GRAPHIC | 92929
99 | GRAPHIC | a201020investorandanalys092.jpg | GRAPHIC | 127415
100 | GRAPHIC | a201020investorandanalys093.jpg | GRAPHIC | 92050
101 | GRAPHIC | a201020investorandanalys094.jpg | GRAPHIC | 119680
102 | GRAPHIC | a201020investorandanalys095.jpg | GRAPHIC | 142881
103 | GRAPHIC | a201020investorandanalys096.jpg | GRAPHIC | 105069
104 | GRAPHIC | a201020investorandanalys097.jpg | GRAPHIC | 105752
105 | GRAPHIC | a201020investorandanalys098.jpg | GRAPHIC | 127248
106 | GRAPHIC | a201020investorandanalys099.jpg | GRAPHIC | 138243
107 | GRAPHIC | a201020investorandanalys100.jpg | GRAPHIC | 60226
108 | GRAPHIC | a201020investorandanalys101.jpg | GRAPHIC | 55683
109 | GRAPHIC | a201020investorandanalys102.jpg | GRAPHIC | 100544
110 | GRAPHIC | a201020investorandanalys103.jpg | GRAPHIC | 93257
111 | GRAPHIC | a201020investorandanalys104.jpg | GRAPHIC | 91722
112 | GRAPHIC | a201020investorandanalys105.jpg | GRAPHIC | 122462
113 | GRAPHIC | a201020investorandanalys106.jpg | GRAPHIC | 104652
114 | GRAPHIC | a201020investorandanalys107.jpg | GRAPHIC | 100254
115 | GRAPHIC | a201020investorandanalys108.jpg | GRAPHIC | 91390
116 | GRAPHIC | a201020investorandanalys109.jpg | GRAPHIC | 78156
117 | GRAPHIC | a201020investorandanalys110.jpg | GRAPHIC | 70460
118 | GRAPHIC | a201020investorandanalys111.jpg | GRAPHIC | 77928
119 | GRAPHIC | a201020investorandanalys112.jpg | GRAPHIC | 61898
120 | GRAPHIC | a201020investorandanalys113.jpg | GRAPHIC | 67753
121 | GRAPHIC | a201020investorandanalys114.jpg | GRAPHIC | 116184
122 | GRAPHIC | a201020investorandanalys115.jpg | GRAPHIC | 111333
123 | GRAPHIC | a201020investorandanalys116.jpg | GRAPHIC | 107301
124 | GRAPHIC | a201020investorandanalys117.jpg | GRAPHIC | 92536
125 | GRAPHIC | a201020investorandanalys118.jpg | GRAPHIC | 104327
126 | GRAPHIC | a201020investorandanalys119.jpg | GRAPHIC | 97067
127 | GRAPHIC | a201020investorandanalys120.jpg | GRAPHIC | 40415
128 | GRAPHIC | a201020investorandanalys121.jpg | GRAPHIC | 46268
129 | GRAPHIC | a201020investorandanalys122.jpg | GRAPHIC | 102186
130 | GRAPHIC | a201020investorandanalys123.jpg | GRAPHIC | 125516
131 | GRAPHIC | a201020investorandanalys124.jpg | GRAPHIC | 100451
132 | GRAPHIC | a201020investorandanalys125.jpg | GRAPHIC | 117289
133 | GRAPHIC | a201020investorandanalys126.jpg | GRAPHIC | 98915
134 | GRAPHIC | a201020investorandanalys127.jpg | GRAPHIC | 120472
135 | GRAPHIC | a201020investorandanalys128.jpg | GRAPHIC | 133009
136 | GRAPHIC | a201020investorandanalys129.jpg | GRAPHIC | 116258
137 | GRAPHIC | a201020investorandanalys130.jpg | GRAPHIC | 116545
138 | GRAPHIC | a201020investorandanalys131.jpg | GRAPHIC | 152228
| Complete submission text file | 0000886163-20-000110.txt |  | 17223667

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20201020.xsd | EX-101.SCH | 2430
4 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20201020_cal.xml | EX-101.CAL | 718
5 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20201020_def.xml | EX-101.DEF | 1655
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20201020_lab.xml | EX-101.LAB | 24270
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20201020_pre.xml | EX-101.PRE | 12654
139 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20201020_htm.xml | XML | 10786

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 201247640
SIC: 2834 Pharmaceutical Preparations